Skip to main content
Clinical Trials/ISRCTN49637686
ISRCTN49637686
Active, not recruiting
未知

Effectiveness and cost-effectiveness of a Collaborative deprescribing intervention of Proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial

ational Association of Pharmacies0 sites222 target enrollmentJune 14, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Overprescribing of proton-pump inhibitors
Sponsor
ational Association of Pharmacies
Enrollment
222
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38530823/ (added 27/03/2024)

Registry
who.int
Start Date
June 14, 2023
End Date
June 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Association of Pharmacies

Eligibility Criteria

Inclusion Criteria

  • 1\. Community\-dwelling older adults, aged 65 years old or over
  • 2\. Continuous use for more than 8 weeks of any PPI (ATC/WHO A02BC– esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole)
  • 3\. Registered at the selected Family Health Units
  • 4\. Access to a telephone

Exclusion Criteria

  • 1\. Live in nursing homes or assisted\-living facilities
  • 2\. Unable to communicate or speak in Portuguese
  • 3\. Have any cognitive impairment or any other condition that does not allow them to understand the study objectives or the questionnaire completion as perceived by the pharmacist.

Outcomes

Primary Outcomes

Not specified

Similar Trials